This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Esomeprazole is a Proton Pump Inhibitor (ppi) used to decrease the production of stomach acid and treat symptoms of acid reflux. In the united states, it is available by prescription or over-the-counter (otc) for short-term treatment of conditions such as Gastroesophageal reflux disease (gerd). Esomeprazole is a prodrug, meaning it is inactive until it is broken down in the body by the enzyme cyp2c19 into its active form, omeprazole. Esomeprazole is used to reduce stomach acid production and prevents the backflow of acid into the esophagus, helping to treat heartburn and other acid reflux symptoms. It is also used to prevent and treat stomach ulcers and can be used in combination with antibiotics to treat helicobacter pylori (h. Pylori) infections, a common cause of stomach ulcers. Esomeprazole is generally well-tolerated but may cause common side effects such as headache, nausea, and diarrhea. It is important to follow the instructions of your doctor or pharmacist when taking this medication.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States